CVS Health Corporation
CVS
$65.51
$0.630.97%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 384.33B | 376.74B | 370.66B | 367.25B | 361.86B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 384.33B | 376.74B | 370.66B | 367.25B | 361.86B |
Cost of Revenue | 333.20B | 325.72B | 321.41B | 316.53B | 309.85B |
Gross Profit | 51.13B | 51.02B | 49.25B | 50.71B | 52.00B |
SG&A Expenses | 41.69B | 41.58B | 41.13B | 41.05B | 40.32B |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 374.89B | 367.31B | 362.54B | 357.59B | 350.17B |
Operating Income | 9.44B | 9.43B | 8.12B | 9.66B | 11.69B |
Income Before Tax | 6.50B | 7.19B | 6.15B | 6.73B | 9.64B |
Income Tax Expenses | 2.01B | 1.94B | 1.56B | 1.72B | 2.44B |
Earnings from Continuing Operations | 4.49K | 5.24K | 4.59K | 5.01K | 7.20K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 42.00M | 36.00M | 28.00M | 6.00M | -14.00M |
Net Income | 4.53B | 5.28B | 4.61B | 5.02B | 7.19B |
EBIT | 9.44B | 9.43B | 8.12B | 9.66B | 11.69B |
EBITDA | 14.07B | 14.05B | 12.72B | 14.24B | 16.24B |
EPS Basic | 3.59 | 4.19 | 3.67 | 3.95 | 5.64 |
Normalized Basic EPS | 4.34 | 4.31 | 3.65 | 4.16 | 5.01 |
EPS Diluted | 3.58 | 4.19 | 3.66 | 3.95 | 5.63 |
Normalized Diluted EPS | 4.33 | 4.30 | 3.64 | 4.15 | 4.99 |
Average Basic Shares Outstanding | 5.05B | 5.04B | 5.03B | 5.06B | 5.09B |
Average Diluted Shares Outstanding | 5.05B | 5.04B | 5.05B | 5.08B | 5.11B |
Dividend Per Share | 2.66 | 2.66 | 2.66 | 2.60 | 2.54 |
Payout Ratio | 74.62% | 63.88% | 73.10% | 66.07% | 45.29% |